Your browser is no longer supported. Please, upgrade your browser.
Settings
CRIS Curis, Inc. daily Stock Chart
CRIS [NASD]
Curis, Inc.
Index- P/E- EPS (ttm)-0.96 Insider Own0.50% Shs Outstand32.57M Perf Week2.22%
Market Cap74.91M Forward P/E- EPS next Y- Insider Trans-32.27% Shs Float27.47M Perf Month42.86%
Income-31.70M PEG- EPS next Q- Inst Own24.70% Short Float1.65% Perf Quarter29.94%
Sales9.70M P/S7.72 EPS this Y45.00% Inst Trans2.35% Short Ratio2.69 Perf Half Y107.21%
Book/sh-0.41 P/B- EPS next Y- ROA-66.70% Target Price9.00 Perf Year36.09%
Cash/sh1.31 P/C1.75 EPS next 5Y- ROE- 52W Range0.60 - 2.90 Perf YTD233.43%
Dividend- P/FCF- EPS past 5Y-5.60% ROI-94.60% 52W High-20.00% Beta2.46
Dividend %- Quick Ratio9.80 Sales past 5Y-7.00% Gross Margin94.40% 52W Low286.67% ATR0.20
Employees31 Current Ratio9.80 Sales Q/Q-28.00% Oper. Margin- RSI (14)61.29 Volatility15.51% 8.99%
OptionableYes Debt/Eq- EPS Q/Q8.30% Profit Margin- Rel Volume1.70 Prev Close2.30
ShortableYes LT Debt/Eq- EarningsAug 13 AMC Payout- Avg Volume168.51K Price2.32
Recom1.00 SMA2015.97% SMA5033.67% SMA20056.05% Volume132,208 Change0.87%
Oct-24-17Initiated Guggenheim Buy $7
Mar-02-16Initiated Sun Trust Rbsn Humphrey Buy $3
Nov-09-15Reiterated ROTH Capital Buy $6 → $5
Aug-11-15Initiated FBR Capital Outperform $6
Jan-22-15Reiterated Oppenheimer Outperform $3 → $5
Jan-21-15Reiterated ROTH Capital Buy $10 → $6
May-09-14Reiterated Oppenheimer Outperform $4.50 → $3
Oct-02-13Initiated Robert W. Baird Outperform $7
Sep-30-13Initiated Chardan Capital Markets Buy $6
Nov-14-12Initiated Stifel Nicolaus Hold
Jan-31-12Reiterated Summer Street Research Buy $5 → $7
Jan-31-12Reiterated Brean Murray Buy $5 → $6
Dec-09-11Initiated Oppenheimer Outperform $6
Oct-06-11Initiated Summer Street Research Buy $5
Sep-22-11Initiated MLV Capital Buy $8.50
Mar-21-11Reiterated Brean Murray Buy $4 → $5
Feb-26-10Reiterated Roth Capital Buy $5 → $4.50
Jan-07-10Initiated Roth Capital Buy $5
Nov-24-09Initiated ThinkEquity Buy
Oct-08-09Initiated Brean Murray Buy $4
Jul-05-19 04:01PM  Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
Jun-12-19 07:00AM  Curis Highlights Publication in Nature Cell Biology Identifying Cancer-Causing Form of IRAK4 in Patients with AML and MDS PR Newswire
May-21-19 11:20AM  Edited Transcript of CRIS earnings conference call or presentation 14-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-14-19 04:29PM  Curis: 1Q Earnings Snapshot Associated Press
04:05PM  Curis Reports First Quarter 2019 Financial Results PR Newswire
May-07-19 08:00AM  Curis to Release First Quarter Financial Results and Hold Conference Call on May 14, 2019 PR Newswire
May-06-19 08:00AM  Curis Completes Mesothelioma Enrollment in CA-170 Study PR Newswire
Apr-26-19 03:13PM  Some Curis (NASDAQ:CRIS) Shareholders Have Taken A Painful 83% Share Price Drop Simply Wall St.
Apr-10-19 08:00AM  Curis Regains Compliance with Nasdaq Continued Listing Requirements PR Newswire
Apr-05-19 04:30PM  Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
Mar-27-19 10:16PM  Edited Transcript of CRIS earnings conference call or presentation 26-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
Mar-26-19 04:17PM  Curis: 4Q Earnings Snapshot Associated Press +6.35%
04:00PM  Curis Reports Fourth Quarter and Year-End 2018 Financial Results PR Newswire
07:36AM  The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs Benzinga
Mar-25-19 12:05PM  What's Driving The Rally In Microcap Biotech Curis? Benzinga +32.17%
11:46AM  Biotech News: Why Curis Stock Is Soaring Today InvestorPlace
09:26AM  Curis' stock rockets on heavy volume after $135.7 million deal to sell portion of Erivedge royalties MarketWatch
08:30AM  Curis Sells Portion of Erivedge Royalties to Oberland Capital for up to $135.7 million PR Newswire
07:30AM  Curis to Release Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call on March 26, 2019 PR Newswire
Mar-04-19 08:00AM  Curis Announces Presentation at Cowen & Company 39th Annual Healthcare Conference PR Newswire +6.60%
Feb-04-19 07:00AM  Curis, Inc. to Present at the 2019 BIO CEO & Investor Conference PR Newswire
Jan-29-19 09:30AM  Has Curis (CRIS) Outpaced Other Medical Stocks This Year? Zacks
Jan-24-19 07:00AM  First Mesothelioma Patient Dosed in CA-170 Study PR Newswire +23.36%
Jan-10-19 05:53PM  First Eagle Investment Sells Stake in Curis Inc. at Steep Loss GuruFocus.com -9.26%
09:30AM  Is Curis (CRIS) Outperforming Other Medical Stocks This Year? Zacks
Jan-08-19 12:58PM  Top 3 Healthcare Penny Stocks for 2018 Investopedia
Jan-04-19 04:00PM  Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire +12.46%
Nov-30-18 07:45AM  Analysis: Positioning to Benefit within Dicerna Pharmaceuticals, Sun Life Financial, Autodesk, Eagle Pharmaceuticals, Curis, and Accenture Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire -6.78%
Nov-20-18 10:45AM  Curis to Present at the 60th Annual Meeting of the American Society of Hematology PR Newswire
Nov-07-18 04:05PM  Curis to Present at 33rd Society for Immunotherapy of Cancer Annual Meeting and Cowen IO NEXT Summit PR Newswire
Nov-05-18 09:09AM  Edited Transcript of CRIS earnings conference call or presentation 1-Nov-18 12:30pm GMT Thomson Reuters StreetEvents -6.98%
Nov-01-18 10:41AM  Curis (CRIS) Reports Q3 Loss, Tops Revenue Estimates Zacks +19.63%
09:04AM  Curis: 3Q Earnings Snapshot Associated Press
07:00AM  Curis Reports Third Quarter 2018 Financial Results PR Newswire
Oct-23-18 04:29PM  Curis to Release Third Quarter Financial Results and Hold Conference Call on November 1, 2018 PR Newswire -5.73%
08:45AM  Investor Expectations to Drive Momentum within Ormat Technologies, The Andersons, Freshpet, Curis, Ultra Clean, and Edge Therapeutics Discovering Underlying Factors of Influence GlobeNewswire
Oct-19-18 10:39AM  Curis (CRIS) Shares March Higher, Can It Continue? Zacks
Oct-10-18 06:44PM  Top 3 Healthcare Penny Stocks for 2018 Investopedia
Oct-05-18 07:00AM  Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
Sep-27-18 11:44AM  Who Are The Top Investors In Curis Inc (NASDAQ:CRIS)? Simply Wall St. +6.79%
Sep-26-18 04:05PM  Curis to Present at the Cantor Fitzgerald Global Healthcare Conference PR Newswire
Sep-24-18 04:22PM  Curis Announces Leadership Change PR Newswire
Aug-29-18 07:45AM  Report: Developing Opportunities within Q2, Ormat Technologies, The Andersons, Comstock Resources, Freshpet, and Curis Future Expectations, Projections Moving into 2018 GlobeNewswire
Aug-28-18 04:14PM  Curis to Present at the Baird 2018 Global Healthcare Conference PR Newswire
Aug-05-18 11:18PM  Edited Transcript of CRIS earnings conference call or presentation 2-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
Aug-02-18 11:50AM  Curis (CRIS) Reports Q2 Loss, Lags Revenue Estimates Zacks -13.92%
10:45AM  Curis: 2Q Earnings Snapshot Associated Press
07:00AM  Curis Reports Second Quarter 2018 Financial Results PR Newswire
Jul-27-18 08:30AM  Curis to Release Second Quarter Financial Results and Hold Conference Call on August 2, 2018 PR Newswire
Jul-26-18 07:55AM  Consolidated Research: 2018 Summary Expectations for At Home Group, Royal Bank Of Canada, Curis, Novavax, HNI, and Freshpet Fundamental Analysis, Key Performance Indications GlobeNewswire
Jul-09-18 10:33AM  Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire +5.71%
Jun-11-18 09:32AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
Jun-01-18 08:00AM  Curis Shares Show Recent Gains, Pipeline Review and FDA Decision ACCESSWIRE -10.43%
May-31-18 03:35PM  Why Curis, Inc. Is Soaring Today Motley Fool +21.93%
08:27AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:00AM  /C O R R E C T I O N -- Curis, Inc./ PR Newswire
May-29-18 10:10AM  Curis Announces Effectiveness of 1-for-5 Reverse Stock Split PR Newswire
May-24-18 07:00AM  Curis Expands Senior Management Expertise with Appointment of Robert Martell, M.D., Ph.D., as Head of Research and Development PR Newswire
May-22-18 05:55PM  Curis Announces 1-for-5 Reverse Stock Split PR Newswire
May-21-18 08:30AM  Factors of Influence in 2018, Key Indicators and Opportunity within MSA Safety Incorporated, Curis, American States Water, AAC, eHealth, and Vista Gold New Research Emphasizes Economic Growth GlobeNewswire -7.27%
May-09-18 03:46AM  Edited Transcript of CRIS earnings conference call or presentation 3-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-03-18 08:59AM  Curis: 1Q Earnings Snapshot Associated Press -10.90%
07:00AM  Curis Reports First Quarter 2018 Financial Results PR Newswire
Apr-26-18 07:00AM  Curis to Release First Quarter 2018 Financial Results and Hold Conference Call on May 3, 2018 PR Newswire
Apr-20-18 05:30PM  Are Earnings Prospects Improving For Loss-Making Curis Incs (NASDAQ:CRIS)? Simply Wall St.
Apr-19-18 07:50AM  Free Post Earnings Research Report: Curis Quarterly Revenue Jumped 38.10% ACCESSWIRE
Apr-06-18 07:00AM  Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire -6.24%
Apr-03-18 08:00AM  Investor Expectations to Drive Momentum within Atrion, Curis, Independence Contract Drilling, Utah Medical Products, FutureFuel, and Opiant Pharmaceuticals Discovering Underlying Factors of Influence GlobeNewswire
Mar-15-18 04:38PM  What Are Analysts Saying About Curis Incs (NASDAQ:CRIS) Earnings Trend? Simply Wall St.
Mar-08-18 10:21PM  Edited Transcript of CRIS earnings conference call or presentation 8-Mar-18 1:30pm GMT Thomson Reuters StreetEvents +31.19%
07:00AM  Curis, Inc. to Host Earnings Call ACCESSWIRE
07:00AM  Curis Reports Fourth Quarter and Year-End 2017 Financial Results PR Newswire
Mar-05-18 07:00AM  Curis to Present at Cowen & Company 38th Annual Health Care Conference PR Newswire +13.47%
Mar-01-18 09:56AM  /C O R R E C T I O N -- Curis, Inc./ PR Newswire
Feb-08-18 07:44AM  Capstone Turbine Corporation (CPST) and Seadrill Ltd (SDRL) Among Hedge Funds Favorite Penny Stocks Insider Monkey
Feb-01-18 07:30AM  Report: Exploring Fundamental Drivers Behind Curis, Mesa Laboratories, Marin Software, Applied Materials, Plug Power, and Amazon New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Jan-17-18 07:00AM  Curis Announces Initiation of Phase 1 Trial of CA-4948, a Small Molecule Inhibitor of IRAK4 Kinase in Patients with Lymphoma PR Newswire
Dec-25-17 11:48AM  ETFs with exposure to Curis, Inc. : December 25, 2017 Capital Cube
Dec-21-17 10:05AM  Want To Invest In Curis Inc (NASDAQ:CRIS)? Heres How It Performed Lately Simply Wall St.
Dec-12-17 01:00PM  ETFs with exposure to Curis, Inc. : December 12, 2017 Capital Cube
Dec-01-17 07:00AM  Curis Announces Upcoming Presentation at the American Society of Hematology 59th Annual Meeting & Exposition GlobeNewswire +10.06%
Nov-30-17 01:41PM  ETFs with exposure to Curis, Inc. : November 30, 2017 Capital Cube
Nov-24-17 02:05PM  Should You Be Concerned About Curis Incs (CRIS) Investors? Simply Wall St.
Nov-20-17 04:04PM  Merck, Cardinal Health Drop into Mondays 52-Week Low Club 24/7 Wall St.
12:03PM  ETFs with exposure to Curis, Inc. : November 20, 2017 Capital Cube
Nov-12-17 06:30PM  Edited Transcript of CRIS earnings conference call or presentation 7-Nov-17 1:30pm GMT Thomson Reuters StreetEvents
Nov-09-17 09:06AM  Curis, Inc. :CRIS-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017 Capital Cube
Nov-08-17 05:49PM  ETFs with exposure to Curis, Inc. : November 8, 2017 Capital Cube +5.51%
12:20PM  Top 3 Healthcare Penny Stocks for 2017 Investopedia
Nov-07-17 08:03AM  What Does Curis Incs (CRIS) Share Price Indicate? Simply Wall St. -15.89%
07:25AM  Curis reports 3Q loss Associated Press
07:00AM  Curis Reports Third Quarter 2017 Financial Results GlobeNewswire
06:30AM  Curis, Inc. to Host Earnings Call ACCESSWIRE
Nov-06-17 08:05AM  Curis, Upcoming SITC Meeting, Aurigene Collaboration and Analysts Review ACCESSWIRE
Nov-03-17 07:00AM  Curis to Present at the Society for Immunotherapy of Cancer 32nd Annual Meeting and the Cowen IO NEXT Summit GlobeNewswire
Nov-01-17 08:45AM  What You Must Know About Curis Incs (CRIS) Financial Strength Simply Wall St.
07:00AM  Curis to Release Third Quarter 2017 Financial Results and Hold Conference Call on November 7, 2017 GlobeNewswire
Sep-22-17 11:54AM  Curis to Present at the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-18-17 06:43PM  Why Curis Inc (CRIS) Could Be A Buy Simply Wall St.
Sep-14-17 07:00AM  Curis Announces Pricing of Public Offering of Common Stock GlobeNewswire -8.00%
Curis, Inc., a biotechnology company, focuses on the development and commercialization of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include CUDC-907, an oral dual inhibitor of HDAC and PI3K enzymes, which is in Phase II clinical trial for the treatment of patients with MYC-altered diffuse large B-cell lymphoma and solid tumors; CA-170, an oral small molecule drug candidate that is in Phase I clinical trial for treating patients with advanced solid tumors and lymphomas; CA-4948, an oral small molecule drug candidate, which is in Phase I clinical trial for the treatment of non-hodgkin lymphomas; and CA-327, an oral small molecule drug candidate that is in preclinical stage for the treatment of cancers. The company has collaboration agreement with F. Hoffmann-La Roche Ltd. and Genentech Inc. for the development and commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway inhibitor for the treatment of advanced basal cell carcinoma; and with Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology. Curis, Inc. was founded in 2000 and is headquartered in Lexington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dentzer James EPresident & CEOJan 24Sale1.163,0943,57741,639Jan 25 04:40 PM
Dentzer James EPresident & CEOJan 23Sale1.092,3972,61344,733Jan 25 04:40 PM
Martell RobertHead of Research & DevelopmentJan 23Sale1.075,5005,90023,027Jan 25 04:40 PM
Rubin MarcDirectorJan 23Sale1.0518,50019,47728,819Jan 25 04:38 PM
GREENACRE MARTYN DDirectorJan 23Sale1.0518,50019,47526,089Jan 25 04:39 PM
KAITIN KENNETH IDirectorJan 23Sale1.0514,80015,58728,121Jan 25 04:37 PM
Kunkel Lori AnneDirectorJan 23Sale1.0514,80015,58122,200Jan 25 04:38 PM